The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology

Ayad yas khudair

2021, Vol: 12, Issue: 3

12 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Review Article

SRP. 2021; 12(3): 512-515

doi: 10.31838/srp.2021.3.74

The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology

Ayad yas khudair.

Abstract
Hepatocellular carcinoma (HCC) is the third largest cause of death among all cancer cases in the world.Moreover, in most cases, it develops against the background of viral hepatitis of the liver. I should be noted, and the fact that the detection of the later stages of the forecast it usually unfavorable.This study focuses on AFP, AFP L 3, and PIVKA II as oncological markers of HCC in patients with chronic viral hepatitis. It was found that the use of the combination of PIVKA II and AFP increases the sensitivity by 16.6% compared with the use of AFP alone, which is comparable with the results of all three-tumor markers.

Key words: HCC, cirrhosis, HBV, HCV, HDV,AFP, AFP L3, PIVKA II, screening.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Ayad yas khudair
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Ayad yas khudair. The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. SRP. 2021; 12(3): 512-515. doi:10.31838/srp.2021.3.74

Web Style

Ayad yas khudair. The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. http://www.sysrevpharm.org/?mno=56499 [Access: March 04, 2021]. doi:10.31838/srp.2021.3.74

AMA (American Medical Association) Style

Ayad yas khudair. The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. SRP. 2021; 12(3): 512-515. doi:10.31838/srp.2021.3.74

Vancouver/ICMJE Style

Ayad yas khudair. The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. SRP. (2021), [cited March 04, 2021]; 12(3): 512-515. doi:10.31838/srp.2021.3.74

Harvard Style

Ayad yas khudair (2021) The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. SRP, 12 (3), 512-515. doi:10.31838/srp.2021.3.74

Turabian Style

Ayad yas khudair. 2021. The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. Systematic Reviews in Pharmacy, 12 (3), 512-515. doi:10.31838/srp.2021.3.74

Chicago Style

Ayad yas khudair. "The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology." Systematic Reviews in Pharmacy 12 (2021), 512-515. doi:10.31838/srp.2021.3.74

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Ayad yas khudair (2021) The diagnostic value of AFP, AFP L3 and PIVKA II in hepatocellular carcinoma outcome of cirrhosis of the liver HBV and HCV etiology. Systematic Reviews in Pharmacy, 12 (3), 512-515. doi:10.31838/srp.2021.3.74

Contact Information

<submissions.srp@gmail.com

How to cite this article

Copyright © 2019 Systematic Reviews in Pharmacy All Rights Reserved. Subject to change without notice from or liability to Systematic Reviews in Pharmacy.

Copyright © 2021 Systematic Reviews in Pharmacy All Rights Reserved. Subject to change without notice from or liability to Systematic Reviews in Pharmacy. For best results, please use Internet Explorer or Google Chrome	Contact Information <submissions.srp@gmail.com